Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
Envista agrees to sell KaVo Treatment Unit and Instrument business to Planmeca
Envista announced a binding agreement to sell its KaVo Treatment Unit and Instrument business to Planmeca for up to $455 million. The sale was expected to close at the end of 2021 and remained subject to customary closing conditions, including regulatory approvals.